Medical Cannabis for Epilepsy: CBD Evidence and Doses
CBD is the only cannabis compound with FDA approval for epilepsy. Epidiolex treats Dravet, Lennox-Gastaut, and tuberous sclerosis. THC has no approval.
The short answer: the only cannabis-based medicine with FDA approval for epilepsy in the United States is Epidiolex, a prescription cannabidiol oral solution for seizures tied to Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. Everything else sold as CBD oil, tincture, or medical cannabis sits outside that approval. I judged the options here on four criteria: FDA approval status, whether controlled trials back the product for a named seizure type, THC content, and how reliably the product can be dosed alongside existing antiseizure medication.
Randomized, placebo-controlled trials of add-on cannabidiol in Dravet and Lennox-Gastaut syndromes reported drops in seizure frequency for some patients. Those trials used a purified, pharmaceutical-grade CBD isolate at fixed doses, with blood monitoring. The results do not transfer automatically to a bottle of unregulated CBD oil with an unknown milligram count. Reported side effects in the trials included drowsiness, diarrhea, decreased appetite, and elevated liver enzymes, which is why liver panels are part of routine follow-up.
Cannabidiol is not a replacement for standard antiseizure drugs. In every major trial it was added to a patient's existing regimen, not swapped in for it.
Medical Cannabis for Epilepsy: Legal States and How Access Works
Best for: anyone with a confirmed Dravet, Lennox-Gastaut, or tuberous sclerosis complex diagnosis who has not reached seizure control on standard therapy.
Best Medical Cannabis Strains for Epilepsy: CBD Picks
Many state medical programs carry products in ratios such as 20:1 CBD to THC. These are what most families mean when they ask about medical cannabis for epilepsy.
Best for: adults and children in a legal medical state whose neurologist agrees to supervise a trial, and who can obtain batch-specific lab testing.
High-THC flower, vapes, and edibles are built for recreational effects, not seizure control.
Best for: adults managing sleep or pain alongside epilepsy, after a neurologist reviews the interaction risk. It is a poor choice as a primary seizure treatment.
For a diagnosed Dravet, Lennox-Gastaut, or tuberous sclerosis complex patient, the prescription CBD path is the one with trial data and clinical supervision behind it. For someone in a medical state who wants to explore cannabis under a neurologist's watch, a lab-tested high-CBD, low-THC tincture is the safer entry point. For adults chasing sleep or pain relief, THC products have a role, but they should not be treated as a seizure medicine. This guide is general information, not medical advice, and epilepsy care belongs with a qualified clinician.